What is the primary use of beta-lactamase inhibitors?

The primary use of beta-lactamase inhibitors is to combat bacterial resistance in severe infections. Beta-lactamase inhibitors are specifically designed to inhibit the action of enzymes produced by certain bacteria, known as beta-lactamases, which can break down and inactivate beta-lactam antibiotics such as penicillins and cephalosporins. By inhibiting these enzymes, these inhibitors protect the antibiotic from degradation, allowing it to remain effective against resistant strains of bacteria.

Using beta-lactamase inhibitors in conjunction with beta-lactam antibiotics expands the spectrum of activity against resistant bacteria, making treatment options more effective during severe infections where traditional beta-lactam antibiotics may not suffice due to resistance mechanisms.

The other options focus on unrelated functions; for instance, enhancing vitamin absorption, treating fungal infections, and preventing viral replication do not pertain to the role of beta-lactamase inhibitors, which are solely focused on aiding beta-lactam antibiotics against resistant bacterial strains.